VERWENDUNG VON EINER IMMUNSTIMULANTEN BIOLOGISTEN SUBSTANZ ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG DES MENSCHLICHEN IMMUNSCHWAECHEVIRUS.

摘要

A method is provided for inhibiting the replication of human immunodeficiency virus (HIV), the etiologic agent responsible for AIDS. The method involves contacting cells infected with HIV virus with a non-toxic, immunostimulating biologic in the presence of white blood cells. The biologic is identified and designated by ATCC accession No. 40105. The method of the invention results in increased Natural Killer and helper/inducer cells, together with a decrease in suppressor cells.